Around 200 million doses of COVID-19 vaccines have been administered so far inside China, with an emphasis on front-line workers, university students and people living in border areas, health officials said.
China is ramping up vaccination efforts after a slow start that was due in part to the virtual elimination of domestic transmission of the coronavirus. Just two local cases were reported on Wednesday, both in the city of Ruili, which borders on Myanmar.
China has approved five domestically produced vaccines and exported millions of doses, although some scientists believe they provide less protection that those by Pfizer, Moderna and AstraZeneca. The Chinese vaccines have an efficacy range of 50.7 percent to 79.3 percent, based on company data, lower than their foreign peers but still effective.
It wasn’t immediately clear how many people had received both their first and second shots of vaccine.
“At present, vaccination efforts in key areas and key population groups are progressing smoothly overall,” Cui Gang, an official with the Center for Disease Control, told reporters at a news conference Wednesday. Already, 80 percent of workers in the health sector have received at least one injection of vaccine, Cui said.
Cities across China have been reporting shortages with some people saying they could not get an appointment to get a second dose, National Health Commission spokesman Mi Feng said. Health officials acknowledged the difficulties and said local governments should aim to make sure the second shot was provided within eight weeks.
China is giving millions of shots a day, and its goal is vaccinating 560 million of the country’s 1.4 billion people by mid-June.
China locked down the city of Wuhan for more than two months starting in January 2020 after the coronavirus was first detected there in late 2019. Wuhan became known as the epicenter of the pandemic, although Beijing has suggested the virus might have been circulating earlier and possibly brought to China from abroad.
Since then, China has controlled the virus through stringent border controls and quick lockdowns whenever new outbreaks crop up. Mask wearing indoors remains almost universal and health tracing applications must be shown at most shops, offices and public buildings.
While China was the first major economy to throw off the effects of the virus, the restrictions are seen as limiting its further growth, particularly as Beijing readies to welcome tens of thousands of visitors as host of the Winter Olympics in February 2022.
Along with the sheer scale of the vaccination effort, authorities need to convince a population that largely no longer feels threatened by infection.
Parts of China face tight COVID-19 vaccine supply: State mediaSome places in China are faced with tight supply of COVID-19 vaccines that has ... Coronavirus
China administers 164.47 million COVID-19 vaccines as of April 10China has administered 164.47 million doses of COVID-19 vaccines as of Saturday, ... Coronavirus
China’s GDP hits record growth but post-COVID economic recovery seen losing momentumChina’s economic recovery quickened sharply in the first quarter to record growth ... Economy